Skip Navigation
Return to All Schools

Rose-Lee and Keith Reinhard Professorship in Urologic Pathology

School of Medicine

Established in 2001 by Rose-Lee and Keith Reinhard

ReinhardRoseKeithROSE-LEE and KEITH REINHARD, New Yorkers who are active in civic affairs, are determined to improve prostate cancer diagnosis and treatment. Mr. Reinhard is chairman emeritus of DDB Worldwide, the largest advertising agency in the U.S. and third largest in the world. Motivated by the fact that the disease runs in families, the couple has become deeply interested in Hopkins research on hereditary prostate cancer. They decided to endow this professorship so that perhaps their sons, grandsons, and other young men at risk for developing the disease might benefit from earlier detection. Mr. Reinhard is a member of the Brady Urological Advisory Council. (Shown at the dedication of the professorship are Dr. Epstein (left) and the Reinhards.)

“I have noticed at Johns Hopkins Medicine this fiery passion and commitment to the mission of seeking answers and saving lives. You can feel it. Johns Hopkins Medicine has a large dream: to eradicate disease from the earth.”

-Keith Reinhard

Held by Jonathan Ira Epstein

JONATHAN IRA EPSTEIN, the inaugural Rose-Lee and Keith Reinhard Professor in Urologic Pathology, completed his postdoctoral training at Johns Hopkins and is currently director of the Division of Surgical Pathology and professor of pathology, urology and oncology. Areas of particular interest are prostatic intraepithelial neoplasia, adenosis, diagnosis of limited adenocarcinoma on needle biopsy, and prediction of progression following radical prostatectomy. He is primary consultant to the Urologic Pathology Laboratory, a nationally recognized center for the study of urological disorders, which Dr. Epstein helped found. He lectures widely, has written more than 240 articles and several books, and has received the Arthur Purdy Stout Surgical Pathology Prize and the American Cancer Society Clinical Oncology Career Development Award.